(MedPage Today) — SAN FRANCISCO — Adding hormone therapy to postoperative radiotherapy did not improve overall survival (OS) for most men with prostate cancer, according to a meta-analysis of individual patient data.
Across six randomized…
Source link : https://www.medpagetoday.com/meetingcoverage/mgucs/120075
Author :
Publish date : 2026-02-27 15:46:00
Copyright for syndicated content belongs to the linked Source.
